文献速递妇科

单细胞测序揭示子宫肌瘤中新的细胞异质性

Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas.
PubMed 文献 · Hum Reprod · 2022-01-01

研究对8例患者的5份MED12变异阳性子宫肌瘤和5份子宫肌层组织行单细胞RNA测序,发现平滑肌细胞、成纤维细胞和内皮细胞群体存在异质性,肌瘤中存在两种特异淋巴管内皮细胞群体,肌瘤与肌层细胞组成相似但转录组不同,单细胞水平证实肌瘤内存在基因型异质性。

要点

  • 子宫肌瘤与子宫肌层在平滑肌细胞、成纤维细胞和内皮细胞群体中均存在细胞异质性。
  • 子宫肌瘤中存在两种特异的淋巴管内皮细胞群体,为肌瘤所特有。
  • 肌瘤与肌层细胞组成相似但转录组不同,成纤维细胞通过与其他细胞互作影响肌瘤微环境。

核心结论

  • 单细胞RNA测序揭示了子宫肌层和MED12变异阳性子宫肌瘤中平滑肌细胞、成纤维细胞和内皮细胞群体的异质性。
  • 肌瘤与肌层细胞组成相对相似但转录组谱不同,且肌瘤内存在基因型异质性。

研究设计与样本

  • 研究收集8例接受子宫切除术患者的5份MED12变异阳性子宫肌瘤和5份子宫肌层样本,行单细胞RNA测序构建细胞图谱。
  • 利用单细胞测序数据定义细胞类型,比较肌瘤与肌层的细胞类型并确定单细胞分辨率下的转录变化,同时在单细胞水平行MED12变异分析。

主要发现

  • 在子宫肌层和子宫肌瘤的平滑肌细胞、成纤维细胞和内皮细胞群体中发现此前未知的异质性。
  • 发现两种仅存在于子宫肌瘤中的淋巴管内皮细胞群体。
  • 子宫肌层与MED12变异肌瘤细胞组成相对相似,但细胞转录组谱不同。
  • 成纤维细胞通过与内皮细胞、免疫细胞和平滑肌细胞互作影响肌瘤微环境。
  • 单细胞水平变异分析显示肌瘤组织平滑肌细胞中同时存在MED12变异和野生型MED12等位基因。

局限性

  • 研究仅对MED12变异阳性肌瘤行单细胞RNA测序分析,携带其他遗传重排的肌瘤可能在细胞组成和转录组谱上有所不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the cellular composition and single-cell transcriptomic differences between myometrium and leiomyomas as defined by single-cell RNA sequencing? SUMMARY ANSWER: We discovered cellular heterogeneity in smooth muscle cells (SMCs), fibroblast and endothelial cell populations in both myometrium and leiomyoma tissues. WHAT IS KNOWN ALREADY: Previous studies have shown the presence of SMCs, fibroblasts, endothelial cells and immune cells in myometrium and leiomyomas. However, there is no information on the cellular heterogeneity in these tissues and the transcriptomic differences at the single-cell level between these tissues. STUDY DESIGN, SIZE, DURATION: We collected five leiomyoma and five myometrium samples from a total of eight patients undergoing hysterectomy. We then performed single-cell RNA sequencing to generate a cell atlas for both tissues. We utilized our single-cell sequencing data to define cell types, compare cell types by tissue type (leiomyoma versus myometrium) and determine the transcriptional changes at a single-cell resolution between leiomyomas and myometrium. Additionally, we performed MED12-variant analysis at the single-cell level to determine the genotype heterogeneity within leiomyomas. PARTICIPANTS/MATERIALS, SETTING, METHODS: We collected five MED12-variant positive leiomyomas and five myometrium samples from a total of eight patients. We then performed single-cell RNA sequencing on freshly isolated single-cell preparations. Histopathological assessment confirmed the identity of the samples. Sanger sequencing was performed to confirm the presence of the MED12 variant in leiomyomas. MAIN RESULTS AND ROLE OF CHANCE: Our data revealed previously unknown heterogeneity in the SMC, fibroblast cell and endothelial cell populations of myometrium and leiomyomas. We discovered the presence of two different lymphatic endothelial cell populations specific to uterine leiomyomas. We showed that both myometrium and MED12-variant leiomyomas are relatively similar in cellular composition but differ in cellular transcriptomic profiles. We found that fibroblasts influence the leiomyoma microenvironment through their interactions with endothelial cells, immune cells and SMCs. Variant analysis at the single-cell level revealed the presence of both MED12 variants as well as the wild-type MED12 allele in SMCs of leiomyomatous tissue. These results indicate genotype heterogeneity of cellular composition within leiomyomas. LARGE SCALE DATA: The datasets are available in the NCBI Gene Expression Omnibus (GEO) using GSE162122. LIMITATIONS, REASONS FOR CAUTION: Our study focused on MED12-variant positive leiomyomas for single-cell RNA sequencing analyses. Leiomyomas carrying other genetic rearrangements may differ in their cellular composition and transcriptomic profiles. WIDER IMPLICATIONS FOR THE FINDINGS: Our study provides a cellular atlas for myometrium and MED12-variant positive leiomyomas as defined by single-cell RNA sequencing. Our analysis provides significant insight into the differences between myometrium and leiomyomas at the single-cell level and reveals hitherto unknown genetic heterogeneity in multiple cell types within human leiomyomas. Our results will be important for future studies into the origin and growth of human leiomyomas. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by funding from the National Institute of Child Health and Human Development (HD098580 and HD088629). The authors declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Goad J, Rudolph J, Zandigohar M, et al. Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas. Hum Reprod. 2022. PMID: 36001050. doi:10.1093/humrep/deac183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。